Reactome | ulixertinib [cytosol]

Schema > ChemicalDrug > Entries

candidateOf	[CandidateSet:R-ALL-9657577] single mechanism MAPK inhibitors [cytosol]
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9657507] Rothfels, Karen, 2019-08-08
crossReference	[DatabaseIdentifier:12020745] Mondo:0004992
dbId	9657506
disease	[Disease:1500689] cancer
displayName	ulixertinib [cytosol]
inDisease	true
literatureReference	[LiteratureReference:9657455] Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
maxDepth	1
name	ulixertinib
referenceEntity	[ReferenceTherapeutic:iuphar.ligand:9210] ulixertinib [Guide to Pharmacology:9210]
schemaClass	ChemicalDrug
stId	R-ALL-9657506

(hasCandidate)

Cite Us!